Skip to main content
. Author manuscript; available in PMC: 2016 May 19.
Published in final edited form as: Gene Ther. 2015 Nov 19;23(2):135–143. doi: 10.1038/gt.2015.105

Figure 5. Seprehvir replication in neuroblastoma xenograft tumors.

Figure 5

Subcutaneously implanted CHLA-20, CHP-134, SK-N-AS and SK-NBE(2) tumors were given a single ITu dose of 107pfu Seprehvir and harvested at 3, 24, 72 and 144 hours post infection for plaque assay. Data are presented as mean plaque forming unit (pfu) per tumor from triplicate plaque assays of four tumors at each time point. Error bars represent s.d. (n=12). Bonferroni corrected pairwise comparisons were made to look for differences in virus yields (PFU) amongst the four groups at 24 hours. ** p<0.01. BDL, below detectable level.